Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity

Details for Australian Patent Application No. 2003286701 (hide)

Owner Merck & Co., Inc.

Inventors Butora, Gabor; Zhou, Changyou; Pasternak, Alexander; Goble, Stephen D.; Yang, Lihu; Mills, Sander G.; Shankaran, Kothandaraman

Agent Spruson & Ferguson

Pub. Number AU-B-2003286701

PCT Number PCT/US2003/0339

PCT Pub. Number WO2004/041161

Priority 60/422,451 30.10.02 US

Filing date 24 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 18 December 2008

International Classifications

C07C 237/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/00 (2006.01)

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 305/08 (2006.01) Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

C07D 307/22 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 309/14 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 311/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 311/02 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 311/68 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 311/74 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 313/04 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

C07D 319/06 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 335/02 (2006.01) Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/422,451 30.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003286701

18 December 2008 Application Accepted

  Published as AU-B-2003286701

23 April 2009 Standard Patent Sealed

28 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003286702-OPTIMIZATION OF A BINARY TREE TRAVERSAL WITH SECURE COMMUNICATIONS

2003286700-DERIVATIVES OF (6,7-DIHYDRO-5H-IMIDAZO(1,2-Alpha )IMIDAZOLE-3-SULFONYL)-PYRROLI DINE-2-CARBOXYLIC ACID AMIDE AS ANTI-INFLAMMATORY AGENTS